Success Metrics

Active Trials
1(25%)

Phase Distribution

Ph phase_3
1
25%
Ph phase_2
2
50%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Other(2)

Detailed Status

unknown2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 22 (50.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)

Trials by Status

recruiting125%
unknown250%
not_yet_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_2

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

NCT05648448
not_yet_recruitingphase_3

Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)

NCT07314905
unknownphase_2

COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)

NCT04327791
unknownphase_4

Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks

NCT05012189

Clinical Trials (4)

Showing 4 of 4 trials
NCT05648448Phase 2

A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Recruiting
NCT07314905Phase 3

Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp)

Not Yet Recruiting
NCT04327791Phase 2

COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)

Unknown
NCT05012189Phase 4

Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4